|Previous Section||Index||Home Page|
Mr. Lansley: To ask the Secretary of State for Health what steps she is taking to improve the consistency of (a) testing and (b) reporting of cases of Clostridium difficile under the mandatory surveillance system. 
In order to improve the quality and consistency of the data, the HPA published criteria for testing and reporting Clostridium difficile under the mandatory surveillance scheme. Microbiology laboratories should test diarrhoeal stools from all patients over 65 years who have not been diagnosed in the past four weeks for evidence of Clostridium difficile associated diarrhoea, by testing specimens for Clostridium difficile toxin using either an immunoassay for both toxin A and toxin B, or a neutralised cell toxicity assay. This requirement was re-emphasised in the professional letter from the Chief Medical Officer, Chief Nursing Officer, Chief Pharmacist and Chief Executive of the national health service in December 2006.
The data for reporting are taken by trusts for their pathology laboratory information management systems and submitted to the HPA. The criteria for reporting were re-stated in the professional letter.
Mandatory surveillance of health care associated infections report 2006, www.hpa.org.uk/infections/topics_az/hai/Mand SurvHCAI2006.pdf
Mr. Lansley: To ask the Secretary of State for Health in which primary care trust areas community hospitals for which bids for capital funding have been received are located; and how much was requested for each community hospital. 
The Department received bids from seven strategic health authorities for a share of the £750 million capital funding available over the next five years for the community hospitals and services project. The primary care trust (PCTs) areas for which capital
funding bids were received, and the amounts requested for each community hospital are listed as follows.
|PCT||Community hospital||Amount of capital funding requested (£ million)|
Mr. Fraser: To ask the Secretary of State for Health (1) how many incontinence (a) pads and (b) pants were supplied by the NHS in each of the last five years; and what steps she is taking to ensure that her Department's guidance Good Practice in Continence Services is fully implemented by NHS trusts; 
Mr. Ivan Lewis: The Department does not collect information on the number of incontinence pads and pants supplied by the national health service, or NHS expenditure on such items. It is for professionals in primary care trusts to commission appropriate services for local people, based on current and anticipated needs, and in consultation with stakeholders. In commissioning these services, professionals are expected to have regard to the recommendations outlined in good practice in continence services.
Mr. Burstow: To ask the Secretary of State for Health how many letters to her Department sent from hon. Members during session 2005-06 remain unanswered, broken down by those which are (a) one, (b) two, (c) three, (d) four and (e) over six months old. 
Mr. Stephen O'Brien: To ask the Secretary of State for Health pursuant to the answer of 8 January 2007, Official Report, column 30W, on the Departmental Commercial Director, if she will undertake to write to the hon. Member for Eddisbury with the relevant details when the fifth member of the panel is confirmed. 
Mr. Ivan Lewis: David Burden will be the fifth member to join the selection panel for the appointment of the Commercial Director General. Mr. Burden is Group Technology Director of the Royal Mail Group plc and a member of the Commercial Advisory Board.
Mr. Newmark: To ask the Secretary of State for Health how many people have been diagnosed with type (a) 1 and (b) 2 diabetes in Braintree, Witham and Halstead Primary Care Trust in each of the last three years. 
Mr. Ivan Lewis: The number of adults aged 18 and over in receipt of direct payments from councils with social services responsibilities in England is given in the following table for the years 2001-02 to 2005-06.
|The number of clients in receipt of direct payments 2001-02 to 2005-06, England|
|Number of clients in receipt of direct payments|
|Rounded numbers( 1)|
| Notes:(1) Data have been rounded to the nearest 1,000 (2) Provisional data. Source: Information Centre, RAP proforma P2f.|
Mrs. Gillan: To ask the Secretary of State for Health what checks the English NHS hospitals in which Welsh patients were treated under the Welsh Assembly Government's second offer scheme made as to whether adequate facilities were available in Wales for any follow-up or remedial surgery required; and what steps the hospitals took to discuss each patient's case with their consultants in Wales before operations were undertaken under the scheme. 
Andy Burnham: The decision to treat patients under the Welsh Assembly Government's second offer scheme is a local decision for the national health service trust or NHS foundation trust concerned. Each organisation will reach agreement with the NHS Wales about the systems for referral and follow-up care.
Mr. Burstow: To ask the Secretary of State for Health what projections her Department has made of the number of cases of (a) MRSA and (b) Clostridium difficile likely to arise in each quarter of each of the next two years, broken down by NHS trust; and if she will make a statement. 
Mr. Burstow: To ask the Secretary of State for Health what projection the Department has made of the change in the number of cases of MRSA likely to have occurred by April 2008; and if she will make a statement. 
Mr. Ivan Lewis: The Department has in place a national target, to halve the rate of meticillin resistant Staphylococcus aureus (MRSA) bloodstream infections by March 2008. Reducing rates of MRSA and other healthcare associated infections is one of the four development priorities in the national health service operating framework for 2007-08.
To ask the Secretary of State for Health pursuant to the answer of 14 November 2005, Official Report, columns 967-98W, on hospital-acquired
infection, on what date the study of deaths associated with healthcare-associated infections started; when she expects the main phase of the study to be completed; whether she plans to publish the report relating to the main phase of the study; whether her Department has received the interim report into the pilot phase of the confidential qualitative study; whether she plans to publish the interim report; and if she will make a statement. 
HPA, Office for National Statistics. National Confidential Study of Deaths Following Healthcare Associated Infection and HPA/ONS Data Linkage Study. Year 1 report (1 August 2005 to 31 July 2006).
London: Health Protection Agency, 2006.
Ms Rosie Winterton: As set out in the written ministerial statement of 17 July 2006, Official Report, column 5WS, 28 out of 34 cancer networks reported that they were HER-2 testing all women diagnosed with early stage breast cancer. The remaining six reported that they would be testing all these women by the end of October 2006. These networks have since reported that they are now HER-2 testing all women with early breast cancer.
Mr. Evennett: To ask the Secretary of State for Health what recent representations she has received on (a) the financial situation and (b) implications for services at Queen Elizabeth Hospital, Woolwich; and if she will make a statement. 
Andy Burnham: Netcare provides services to national health service patients through the independent sector treatment centre programme. Netcare currently provides the Greater Manchester Surgical Centre and the mobile ophthalmic service.
|Next Section||Index||Home Page|